LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - Summit Therapeutics (NASDAQ: SMMT)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ SMMT Summit Therapeutics
Xia Yu / director
10/21/2025
Buy
$18.74
533,617
$10.000M
32.06M
NASDAQ SMMT Summit Therapeutics
Anand Bhaskar / officer: Chief Accounting Officer
10/21/2025
Buy
$18.74
26,680
$500K
159,751
NASDAQ SMMT Summit Therapeutics
Soni Manmeet Singh / director, officer: COO and CFO
10/21/2025
Buy
$18.74
53,361
$1,000K
3.07M
NASDAQ SMMT Summit Therapeutics
DUGGAN ROBERT W / director, 10 percent owner, officer: Co-Chief Executive Officer
10/21/2025
Buy
$18.74
13.98M
$262.000M
570.07M
NASDAQ SMMT Summit Therapeutics
DUGGAN ROBERT W / director, 10 percent owner, officer: Co-Chief Executive Officer
10/21/2025
Buy
$18.74
266,808
$5.000M
25.72M
NASDAQ SMMT Summit Therapeutics
DUGGAN ROBERT W / director, 10 percent owner, officer: Co-Chief Executive Officer
10/21/2025
Buy
$18.74
26,680
$500K
76,680
NASDAQ SMMT Summit Therapeutics
Zanganeh Mahkam / director, 10 percent owner, officer: Co-Chief Executive Officer
10/21/2025
Buy
$18.74
13.98M
$262.000M
570.07M
NASDAQ SMMT Summit Therapeutics
Zanganeh Mahkam / director, 10 percent owner, officer: Co-Chief Executive Officer
10/21/2025
Buy
$18.74
266,808
$5.000M
25.72M
NASDAQ SMMT Summit Therapeutics
Zanganeh Mahkam / director, 10 percent owner, officer: Co-Chief Executive Officer
10/21/2025
Buy
$18.74
26,680
$500K
76,680
NASDAQ SMMT Summit Therapeutics
Anand Bhaskar / officer: Chief Accounting Officer
09/18/2025
Buy
$19.23
50,000
$962K
50,000
NASDAQ SMMT Summit Therapeutics
Zanganeh Mahkam / director, 10 percent owner, officer: Co-Chief Executive Officer
09/11/2025
Buy
$18.07
5,000
$90K
556.09M
NASDAQ SMMT Summit Therapeutics
Zanganeh Mahkam / director, 10 percent owner, officer: Co-Chief Executive Officer
09/10/2025
Buy
$17.68
333,394
$5.894M
556.09M
NASDAQ SMMT Summit Therapeutics
DUGGAN ROBERT W / director, 10 percent owner, officer: Co-Chief Executive Officer
09/11/2025
Buy
$18.07
5,000
$90K
556.09M
NASDAQ SMMT Summit Therapeutics
DUGGAN ROBERT W / director, 10 percent owner, officer: Co-Chief Executive Officer
09/10/2025
Buy
$17.68
333,394
$5.894M
556.09M